Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | CPT2 | P23786 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 4/20 | 0.42 |
| ▸ | FDPS | P14324 | 7/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.39 |
| ▸ | CCR2 | P41597 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897269 | 0.98 | FFAR1 (0.56) | FFAR1CPT2TDP1CES2FDPS | |
| SCHEMBL1781887 | 0.93 | TDP1 (0.48) | FFAR1CPT2TDP1CES2FDPS | |
| SCHEMBL1784497 | 0.83 | TDP1 (0.41) | FFAR1CPT2TDP1CES2FDPS | |
| SCHEMBL1410746 | 0.82 | FFAR1 (0.52) | FFAR1CPT2TDP1CES2FDPS | |
| SCHEMBL8087636 | 0.82 | TDP1 (0.78) | FFAR1CPT2TDP1 | |
| SCHEMBL9686294 | 0.82 | TDP1 (0.46) | FFAR1CPT2TDP1 | |
| SCHEMBL7047662 | 0.81 | FFAR1 (0.44) | FFAR1CPT2TDP1FDPSGGPS1 | |
| SCHEMBL5878804 | 0.80 | TDP1 (0.83) | FFAR1CPT2TDP1 | |
| SCHEMBL20184209 | 0.80 | TDP1 (0.83) | FFAR1CPT2TDP1 | |
| SCHEMBL22748689 | 0.80 | TDP1 (0.83) | FFAR1CPT2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | FFAR1 229/4885CPT2 1087/4885TDP1 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.